IMM 1.61% 31.5¢ immutep limited

trading on nasdaq, page-2

  1. 2,977 Posts.
    lightbulb Created with Sketch. 23
    There is no doubt that once PRR lists on the NASDAQ we will see a massive spike in the share price.

    An example of another biotech company is UNS. In the month leading to listing it went from $1.055 to $1.40. Upon listing it shot to $1.78. It has now retraced to $0.82 due to mismanagement etc.

    PRR is a diffferent kettle of fish though with more potential. If UNS was able to go up 70%, PRR will be able to double it's current price upon listing.

    Please DYOR as my research is based on historical data and events.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.